Reversible Epigenetic Alterations Mediate PSMA Expression Heterogeneity in Advanced Metastatic Prostate Cancer

Investigators demonstrated that prostate-specific membrane antigen (PSMA) expression was heterogeneous across different metastatic sites and molecular subtypes of metastatic castration-resistant prostate cancer.